The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach.

Wranik, Wieslawa Dominika; Székely, Ronaldo-Raul; Mayer, Susanne; Hiligsmann, Mickaël; Cheung, Kei Long

Wranik, Wieslawa Dominika; Székely, Ronaldo-Raul; Mayer, Susanne; Hiligsmann, Mickaël; Cheung, Kei Long.

Afiliação

Wranik WD; Faculty of Management, School of Public Administration, Dalhousie University, Halifax, Canada.
Székely RR; Faculty of Medicine, Department of Community Health and Epidemiology, Dalhousie University, Halifax, Canada.
Mayer S; Jean Monnet European Union Centre of Excellence, Dalhousie University, Halifax, Canada.
Hiligsmann M; Division of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Cheung KL; Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria.

J Med Econ ; 24(1): 846-856, 2021.

Article em En | MEDLINE | ID: mdl-34162282

Assuntos

Tomada de Decisões; Avaliação da Tecnologia Biomédica; Teorema de Bayes; Canadá; Atenção à Saúde; Humanos

Palavras-chave

Canadian Pharmacare; Health Technology Assessment; I; I1; I11; I12; bestworst scaling; relative importance scores; selection of pharmaceuticals

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Tomada de Decisões Tipo de estudo: Health_technology_assessment / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google